Sargramostim Injection |
GM-CSF; Leukine; Prokine |
Article: Granulocyte macrophage colony-stimulating factor
| Image:Granulocyte macrophage colony-stimulating factor.png | |
| Granulocyte macrophage colony-stimulating factor | |
| Systematic (IUPAC) name | |
| Human granulocyte macrophage colony stimulating factor | |
| Identifiers | |
| CAS number | 83869-56-1 |
| ATC code | L03AA09 |
| PubChem | ? |
| DrugBank | BTD00035 |
| Chemical data | |
| Formula | C639H1006N168O196S8 |
| Mol. weight | 14434.5 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | |
| Routes | ? |
Granulocyte macrophage colony-stimulating factor, often abbreviated to GM-CSF, is a protein secreted by macrophages that stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and macrophages. It is thus part of the immune/inflammatory cascade, whereby activation of a small number of macrophages produces more of them in circulation.
Granulocyte macrophage colony-stimulating factor is distinct from granulocyte colony-stimulating factor.
Also known as sargramostim when the protein is expressed in yeast cells (trademarked Leukine®), granulocyte macrophage colony-stimulating factor is used as a medication to stimulate the production of white blood cells, especially granulocytes and macrophages, following chemotherapy.
Categories: Medicine stubs | Blood

Not Signed In -


